Skip to main content

Table 1 Clinical pathological characteristics of our patients' series

From: Survival prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy treatment: analysis from a single oncological center

Variables No. of patients Percentage
Median age 59.6 ± 10.58 years old  
M/F 26/38  
CRS without HIPEC 5 7.8
CRS + HIPEC 59 92.2
Primary tumor:   
• Colon 22 34.4
• Gastric 21 32.8
• Ovary 9 14.1
• Other tumor with malignant ascites 3 4.7
• Other 4 6.2
Performance Karnovsky Status (PKS) > 90% 58 90.6
Median PCI 2  
CC:   
• 0 50 89.3
• 1 4 7.1
• 2 2 3.6
Neoadjuvant chemotherapy 15 25.4
Adjutant chemotherapy 55 93.2
Adjutant HIPEC 12 20.3
Palliative HIPEC 3 5.1
Intraoperative drugs:   
• Cysp. + Myto 34 57.6
• Oxaliplatin 14 23.7
• Doxo 4 6.8
• Other 7 11.9